Attention Dysregulation in Breast Cancer Patients Following a Complementary Alternative Treatment Routine: A Double-Blind Randomized Trial

Talya Dolev, Merav Ben-David, Ilanit Shahadi, Yaakov Freed, Salman Zubedat, Shlomit Aga-Mizrachi, Zev Brand, Shira Galper, Galia Jacobson, Avi Avital, Talya Dolev, Merav Ben-David, Ilanit Shahadi, Yaakov Freed, Salman Zubedat, Shlomit Aga-Mizrachi, Zev Brand, Shira Galper, Galia Jacobson, Avi Avital

Abstract

Introduction: Breast cancer patients and survivors frequently report fatigue, emotional, and cognitive disturbances, which reduce performance at all levels of occupation and make life quality issues a considerable clinical concern. The aim of this study is to evaluate attention and emotion regulation across radiotherapy period and the possible effects of complementary alternative medicine (CAM).

Methods: Fifty-seven patients with unilateral breast cancer underwent surgery and systemic chemotherapy before participating in this double-blind randomized study. Two thirds were given CAM (n = 38) while the rest received placebo (carrier only, n = 19). Patients' attention and anxiety were physiologically tested at baseline, 2 and 4 weeks during the radiation period as well as 1-month after the end of radiation session.

Results: Both groups showed similar levels of anxiety with no significant differences at baseline nor post-radiotherapy. Long-term significant recovery of attention performance was observed in the CAM patients, accompanied by a similar tendency in anxiety level, measured by the eye-blink probability.

Conclusions: This study physiologically validates the attention impairment reported among breast cancer survivors; also, it depicted a beneficial late-effect of a routine CAM on attention dysregulation. The suggested non-invasive physiological measures can physiologically monitor patients' psychological and cognitive well-being as well as evaluate the beneficial effect of CAM in breast cancer patients by assessing their coping ability to support the treatment plan. Thus, the results have potential clinical implications on patients' and survivors' quality of life.

Trial registration: NIH, NCT02890316. Registered July 2016, http://www.ClinicalTrials.gov.

Keywords: anxiety; attention; breast cancer; complementary alternative medicine; dysregulation; emotion; fatigue; homeopathy; radiotherapy.

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Avi Avital discloses a patent (16/541,517) of the ASAT “an EMG-based method to evaluate attention”. All other authors declare that they have no competing interests.

Figures

Figure 1.
Figure 1.
Enrollment flow chart.
Figure 2.
Figure 2.
Startle response intensity during and post-radiations. No emotional dysregulation effect was found in both treated and non-treated groups according to the startle response during and post-radiation period.
Figure 3.
Figure 3.
Electro-dermal activity during and post-radiations. No emotional effect over anxiety level was found in both treated and non-treated groups according to the EDR during and post radiation period.
Figure 4.
Figure 4.
Startle response probability during and post-radiations. Radiotherapy had a non-significant tendency to decrease the probability of producing eye-blinks following an acoustic startling pulse as observed in the placebo group, while the homeopathic treatment preserved baseline performance level.
Figure 5.
Figure 5.
Response inhibition during and post-radiation. Homeopathic treatment ameliorated the radiotherapy-induced decrease in cognitive performance back to baseline level as observed 1-month after the end of radiation period. *P < .035.
Figure 6.
Figure 6.
Representative signals of the startle response inhibition between groups. The placebo-control group (a) inhibited 9% of the baseline startle response while the treated group (b) inhibited 19% of the baseline startle response intensity.

References

    1. Byar KL, Berger AM, Bakken SL, Cetak MA. Impact of adjuvant breast cancer chemotherapy on fatigue, other symptoms, and quality of life. Oncol Nurs Forum. 2006;33:E18-E26. doi:10.1188/06.ONF.E18-E26
    1. So WKW, Marsh G, Ling WM, et al.. Anxiety, depression and quality of life among Chinese breast cancer patients during adjuvant therapy. Eur J Oncol Nurs. 2010;14:17-22. doi:10.1016/j.ejon.2009.07.005
    1. Lim CC, Kamala Devi M, Ang E. Anxiety in women with breast cancer undergoing treatment: a systematic review. Int J Evid Based Healthc. 2011;9:215-235. doi:10.1111/j.1744-1609.2011.00221.x
    1. Cheung YT, Shwe M, Tan YP, Fan G, Ng R, Chan A. Cognitive changes in multiethnic Asian breast cancer patients: a focus group study. Ann Oncol. 2012;23:2547-2552. doi:10.1093/annonc/mds029
    1. Van Esch L, Roukema JA, Ernst MF, Nieuwenhuijzen GAP, De Vries J. Combined anxiety and depressive symptoms before diagnosis of breast cancer. J Affect Disord. 2012;136:895-901. doi:10.1016/j.jad.2011.09.012
    1. Cheung YT, Lee HHL, Chan A. Exploring clinical determinants and anxiety symptom domains among Asian breast cancer patients. Support Care Cancer. 2013;21:2185-2194. doi:10.1007/s00520-013-1769-8
    1. Root JC, Ryan E, Barnett G, Andreotti C, Bolutayo K, Ahles T. Learning and memory performance in a cohort of clinically referred breast cancer survivors: the role of attention versus forgetting in patient-reported memory complaints. Psychooncology. 2015;24:548-555. doi:10.1002/pon.3615
    1. Cheung YT, Ong YY, Ng T, et al.. Assessment of mental health literacy in patients with breast cancer. J Oncol Pharm Pract. 2016;22:437-447. doi:10.1177/1078155215587541
    1. Jacobsen PB, Hann DM, Azzarello LM, Horton J, Balducci L, Lyman GH. Fatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course, and correlates. J Pain Symptom Manage. 1999;18:233-242. doi:10.1016/S0885-3924(99)00082-2
    1. Servaes P, Verhagen C, Bleijenberg G. Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. Eur J Cancer. 2002;38:27-43. doi:10.1016/S0959-8049(01)00332-X
    1. Lawrence DP. Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients. J Natl Cancer Inst Monogr. 2004;2004:40-50. doi:10.1093/jncimonographs/lgh027
    1. Bower JE. Behavioral symptoms in patients with breast cancer and survivors. J Clin Oncol. 2008;26:768-777. doi:10.1200/JCO.2007.14.3248
    1. Andrykowski MA, Curran SL, Lightner R. Off-treatment fatigue in breast cancer survivors: a controlled comparison. J Behav Med. 1998;21:1-18. doi:10.1023/A:1018700303959
    1. Graydon JE. Women with breast cancer: their quality of life following a course of radiation therapy. J Adv Nurs. 1994;19:617-622. doi:10.1111/j.1365-2648.1994.tb01131.x
    1. Schmidt ME, Chang-Claude J, Vrieling A, Heinz J, Flesch-Janys D, Steindorf K. Fatigue and quality of life in breast cancer survivors: temporal courses and long-term pattern. J Cancer Surviv. 2012;6:11-19. doi:10.1007/s11764-011-0197-3
    1. Cella D, Davis K, Breitbart W, Curt G. Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol. 2001;19:3385-3391. doi:10.1200/JCO.2001.19.14.3385
    1. Bower JE, Ganz PA, Desmond KA, et al.. Fatigue in long-term breast carcinoma survivors. Cancer. 2006;106:751-758. doi:10.1002/cncr.21671
    1. Servaes P, Gielissen MFM, Verhagen S, Bleijenberg G. The course of severe fatigue in disease-free breast cancer patients: a longitudinal study. Psychooncology. 2007;16:787-795. doi:10.1002/pon.1120
    1. Reinertsen KV, Cvancarova M, Loge JH, Edvardsen H, Wist E, Fosså SD. Predictors and course of chronic fatigue in long-term breast cancer survivors. J Cancer Surviv. 2010;4:405-414. doi:10.1007/s11764-010-0145-7
    1. Noal S, Levy C, Hardouin A, et al.. One-year longitudinal study of fatigue, cognitive functions, and quality of life after adjuvant radiotherapy for breast cancer. Int J Radiat Oncol Biol Phys. 2011;81:795-803. doi:10.1016/j.ijrobp.2010.06.037
    1. Poulson MJ. Not just tired. J Clin Oncol. 2003;21:112s-113s. doi:10.1200/JCO.2003.01.191
    1. Crosswell AD, Lockwood KG, Ganz PA, Bower JE. Low heart rate variability and cancer-related fatigue in breast cancer survivors. Psychoneuroendocrinology. 2014;45:58-66. doi:10.1016/j.psyneuen.2014.03.011
    1. Jereczek-Fossa BA, Marsiglia HR, Orecchia R. Radiotherapy-related fatigue. Crit Rev Oncol Hematol. 2002;41:317-325. doi:10.1016/S1040-8428(01)00143-3
    1. Gullett JM, Cohen RA, Yang GS, et al.. Relationship of fatigue with cognitive performance in women with early-stage breast cancer over 2 years. Psychooncology. 2019;28:997-1003. doi:10.1002/pon.5028
    1. Frank JS, Vance DE, Jukkala A, Meneses KM. Attention and memory deficits in breast cancer survivors. J Neurosci Nurs. 2014;46:274-284. doi:10.1097/JNN.0000000000000078
    1. Van der Willik KD, Koppelmans V, Hauptmann M, Compter A, Ikram MA, Schagen SB. Inflammation markers and cognitive performance in breast cancer survivors 20 years after completion of chemotherapy: a cohort study. Breast Cancer Res. 2018;20:135. doi:10.1186/s13058-018-1062-3
    1. Seigers R, Fardell JE. Neurobiological basis of chemotherapy-induced cognitive impairment: a review of rodent research. Neurosci Biobehav Rev. 2011;35:729-741. doi:10.1016/j.neubiorev.2010.09.006
    1. Chen X, He X, Tao L, et al.. The attention network changes in breast cancer patients receiving neoadjuvant chemotherapy: evidence from an arterial spin labeling perfusion study. Sci Rep. 2017;7:42684. doi:10.1038/srep42684
    1. Shen CY, Chen VCH, Yeh DC, et al.. Association of functional dorsal attention network alterations with breast cancer and chemotherapy. Sci Rep. 2019;9:104. doi:10.1038/s41598-018-36380-6
    1. Kam JWY, Brenner CA, Handy TC, et al.. Sustained attention abnormalities in breast cancer survivors with cognitive deficits post chemotherapy: an electrophysiological study. Clin Neurophysiol. 2016;127:369-378. doi:10.1016/j.clinph.2015.03.007
    1. Minton O, Stone PC. A comparison of cognitive function, sleep and activity levels in disease-free breast cancer patients with or without cancer-related fatigue syndrome. BMJ Support Palliat Care. 2012;2:231-238. doi:10.1136/bmjspcare-2011-000172
    1. McGhie A, Chapman J. Disorders of attention and perception in early schizophrenia. Br J Med Psychol. 1961;34:103-116. doi:10.1111/j.2044-8341.1961.tb00936.x
    1. Schmitz R, Deliens G, Mary A, Urbain C, Peigneux P. Selective modulations of attentional asymmetries after sleep deprivation. Neuropsychologia. 2011;49:3351-3360. doi:10.1016/j.neuropsychologia.2011.08.009
    1. Benwell CSY, Harvey M, Gardner S, Thut G. Stimulus- and state-dependence of systematic bias in spatial attention: additive effects of stimulus-size and time-on-task. Cortex. 2013;49:827-836. doi:10.1016/j.cortex.2011.12.007
    1. Van der Linden D, Massar SAA, Schellekens AFA, Ellenbroek BA, Verkes RJ. Disrupted sensorimotor gating due to mental fatigue: preliminary evidence. Int J Psychophysiol. 2006;62:168-174. doi:10.1016/j.ijpsycho.2006.04.001
    1. Alhola P, Polo-Kantola P. Sleep deprivation: impact on cognitive performance. Neuropsychiatr Dis Treat. 2007;3:553-567.
    1. McCoy JG, Strecker RE. The cognitive cost of sleep lost. Neurobiol Learn Mem. 2011;96:564-582. doi:10.1016/j.nlm.2011.07.004
    1. Curcio G, Ferrara M, De Gennaro L. Sleep loss, learning capacity and academic performance. Sleep Med Rev. 2006;10:323-337. doi:10.1016/j.smrv.2005.11.001
    1. Tsaras K, Papathanasiou I V., Mitsi D, et al.. Assessment of depression and anxiety in breast cancer patients: prevalence and associated factors. Asian Pacific J Cancer Prev. 2018;19:1661-1669. doi:10.22034/APJCP.2018.19.6.1661
    1. Faye-Schjøll HH, Schou-Bredal I. Pessimism predicts anxiety and depression in breast cancer survivors: a 5-year follow-up study. Psychooncology. 2019;28:1314-1320. doi:10.1002/pon.5084
    1. Kugbey N, Oppong Asante K, Meyer-Weitz A. Depression, anxiety and quality of life among women living with breast cancer in Ghana: mediating roles of social support and religiosity. Support Care Cancer. 2020;28:2581-2588. doi:10.1007/s00520-019-05027-1
    1. Ng CG, Mohamed S, Kaur K, Sulaiman AH, Zainal NZ, Taib NA. Perceived distress and its association with depression and anxiety in breast cancer patients. Ho Y-S, ed. PLoS One. 2017;12:e0172975. doi:10.1371/journal.pone.0172975
    1. Molina V, Montes C, Tamayo P, et al.. Correlation between prepulse inhibition and cortical perfusion during an attentional test in schizophrenia. A pilot study. Prog Neuro-Psychopharmacol Biol Psychiatry. 2009;33:53-61. doi:10.1016/j.pnpbp.2008.10.011
    1. Avital A, Dolev T, Aga-Mizrachi S, Zubedat S. Environmental enrichment preceding early adulthood methylphenidate treatment leads to long term increase of corticosterone and testosterone in the rat. Burne T, ed. PLoS One. 2011;6:e22059. doi:10.1371/journal.pone.0022059
    1. Zubedat S, Aga-Mizrachi S, Cymerblit-Sabba A, et al.. Human-animal interface: the effects of handler’s stress on the performance of canines in an explosive detection task. Appl Anim Behav Sci. 2014;158:69-75. doi:10.1016/j.applanim.2014.05.004
    1. Frass M, Friehs H, Thallinger C, et al.. Influence of adjunctive classical homeopathy on global health status and subjective wellbeing in cancer patients - a pragmatic randomized controlled trial. Complement Ther Med. 2015;23:309-317. doi:10.1016/j.ctim.2015.03.004
    1. Molassiotis A, Fernández-Ortega P, Pud D, et al.. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol. 2005;16:655-663. doi:10.1093/annonc/mdi110
    1. Samuels N, Freed Y, Weitzen R, et al.. Feasibility of homeopathic treatment for symptom reduction in an integrative oncology service. Integr Cancer Ther. 2018;17:486-492. doi:10.1177/1534735417736133
    1. Rostock M, Naumann J, Guethlin C, Guenther L, Bartsch HH, Walach H. Classical homeopathy in the treatment of cancer patients - a prospective observational study of two independent cohorts. BMC Cancer. 2011;11:19. doi:10.1186/1471-2407-11-19
    1. Frass M, Lechleitner P, Gründling C, et al.. Homeopathic Treatment as an add-on therapy may improve quality of life and prolong survival in patients with non-small cell lung cancer: a prospective, randomized, placebo-controlled, double-blind, three-arm, multicenter study. Oncologist. 2020;25:e1930-e1955. doi:10.1002/onco.13548
    1. Gleiss A, Frass M, Gaertner K. Re-analysis of survival data of cancer patients utilizing additive homeopathy. Complement Ther Med. 2016;27:65-67. doi:10.1016/j.ctim.2016.06.001
    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7-34. doi:10.3322/caac.21551
    1. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 2010;8:18. doi:10.1186/1741-7015-8-18
    1. Hahnemann S. Organon of Medicine. W.F. Wakeman; 2002. Accessed November 26, 2019.
    1. O’Connor JT. American Homoeopathic Pharmacopoeia. Boericke & Tafel; 1896.
    1. Clarke J. A Dictionary of Pratical Materia Medica. Homoeopathic Publishing Company; 1902.
    1. Association IH. Proceedings. The Association; 1897.
    1. Templeton W, Hom F. The British Homoeopathic Journal. 1954;44. Accessed November 26, 2019.
    1. Zubedat S, Havkin E, Maoz I, Aga-Mizrachi S, Avital A. A probabilistic model of startle response reveals opposite effects of acute versus chronic Methylphenidate treatment. J Neurosci Methods. 2019;327:108389. doi:10.1016/j.jneumeth.2019.108389
    1. Shapiro M, Melmed RN, Sgan-Cohen HD, Eli I, Parush S. Behavioural and physiological effect of dental environment sensory adaptation on children’s dental anxiety. Eur J Oral Sci. 2007;115:479-483. doi:10.1111/j.1600-0722.2007.00490.x
    1. Okkesim Ş, Kara S, Kaya MG, Asyali MH. Analysis of coronary angiography related psychophysiological responses. Biomed Eng Online. 2011;10:71. doi:10.1186/1475-925X-10-71
    1. Portenoy RK, Itri LM. Cancer-related fatigue: guidelines for evaluation and management. Oncologist. 1999;4:1-10.
    1. Mock V, Atkinson A, Barsevick A, et al.. NCCN practice guidelines for cancer-related fatigue. Oncology (Williston Park). 2000;14:151-161.
    1. Biglia N, Bounous VE, Malabaila A, et al.. Objective and self-reported cognitive dysfunction in breast cancer women treated with chemotherapy: a prospective study. Eur J Cancer Care (Engl). 2012;21:485-492. doi:10.1111/j.1365-2354.2011.01320.x
    1. Wagner L, Sweet J, Butt Z, Lai J, Oncol DC-JS, 2009. U. Measuring patient self-reported cognitive function: development of the functional assessment of cancer therapy-cognitive function instrument. J Support Oncol. 2009;7:W32-W39.
    1. Inagaki M, Yoshikawa E, Matsuoka Y, et al.. Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer. 2007;109:146-156. doi:10.1002/cncr.22368
    1. Silverman DHS, Dy CJ, Castellon SA, et al.. Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy. Breast Cancer Res Treat. 2007;103:303-311. doi:10.1007/s10549-006-9380-z
    1. Chen X, Li J, Ren J, et al.. Selective impairment of attention networks in breast cancer patients receiving chemotherapy treatment. Psychooncology. 2014;23:1165-1171. doi:10.1002/pon.3539
    1. Valentine AD, Meyers CA. Cognitive and mood disturbance as causes and symptoms of fatigue in cancer patients. Cancer. 2001;92:1694-1698. doi:10.1002/1097-0142(20010915)92:6+<1694::AID-CNCR1499>;2-S
    1. St. Clair Gibson A, Baden DA, Lambert MI, et al.. The conscious perception of the sensation of fatigue. Sport Med. 2003;33:167-176. doi:10.2165/00007256-200333030-00001
    1. Noakes TD. Fatigue is a brain-derived emotion that regulates the exercise behavior to ensure the protection of whole body homeostasis. Front Physiol. 2012;3:82. doi:10.3389/fphys.2012.00082
    1. Lohrisch C. Cognition effects of chemotherapy. Breast Cancer Res. 2000;2:66696. doi:10.1186/bcr-2000-66696
    1. Tung A, Szafran MJ, Bluhm B, Mendelson WB. Sleep deprivation potentiates the onset and duration of loss of righting reflex induced by propofol and isoflurane. Anesthesiology. 2002;97:906-911. doi:10.1097/00000542-200210000-00024
    1. Marciel kelli K. National institute of health state-of-the-science conference statement: symptom management in cancer: pain, depression, and fatigue, July 15-17, 2002. J Natl Cancer Inst. 2003;95:1110-1117. doi:10.1093/jnci/djg014

Source: PubMed

3
Tilaa